Publications by authors named "Doris Soebbing"

Claim this Profile
I
Immune thrombocytopenia in patients treated with immune checkpoint inhibitors.
Rebecca Karp Leaf, Jodi V Mones, Tushar Shenoy, Mohamed Warsame, Marina Beltrami-Moreira, Doris R Soebbing

Blood· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of a phase I trial with Haploidentical mbIL-21 ex vivo expanded NK cells for patients with multiply relapsed and refractory AML.
Stefan O Ciurea, Piyanuch Kongtim, Samer Srour, Julianne Chen, Doris Soebbing

Am J Hematol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decrease post-transplant relapse using donor-derived expanded NK-cells.
Stefan O Ciurea, Piyanuch Kongtim, Doris Soebbing, Prashant Trikha, Gregory Behbehani

Leukemia· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pilot study using post-transplant cyclophosphamide (PTCy), tacrolimus and mycophenolate GVHD prophylaxis for older patients receiving 10/10 HLA-matched unrelated donor hematopoietic stem cell transplantation.
Mithun Vinod Shah, Rima M Saliba, Gabriela Rondon, Julianne Chen, Doris Soebbing

Bone Marrow Transplant· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 clinical trial using mbIL21 ex vivo-expanded donor-derived NK cells after haploidentical transplantation.
Stefan O Ciurea, Jolie R Schafer, Roland Bassett, Cecele J Denman, Kai Cao, Doris Soebbing

Blood· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis